CRISPR-Based Detection of Viral Hemorrhagic Fevers at the Point of Care
Viruses · 2026
DOI: 10.3390/v18020218 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2026. Verfasst von Kylene Wupori und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada. Hauptthemen laut MEDLINE: Hemorrhagic Fevers, Viral, Point-of-Care Systems, Molecular Diagnostic Techniques, CRISPR-Cas Systems. Die Arbeit nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Genomics Research and Development Initiative, Canadian Safety and Security Program, Genomics Research and Development Initiative-8.
Abstract (Originalsprache)
Viral hemorrhagic fevers (VHFs) are highly lethal diseases that often present non-specific, influenza-like symptoms in their early stages, making clinical recognition and differentiation from other febrile illnesses difficult. This overlap underscores the critical need for diagnostic tests that are both sensitive and specific. Point-of-care (POC) diagnostic tests are an invaluable tool for detecting and controlling the spread of pathogens that threaten public health, such as VHFs, as these require fast, accurate diagnostics to ensure biosafety and appropriate mobilization of resources during outbreaks. Current molecular and serological diagnostic tests, while efficient and effective, lack the characteristics required of a POC test (POCT) to quickly and easily respond to a VHF outbreak while maintaining a low cost. Clustered regularly interspaced short palindromic repeats (CRISPR)-based diagnostic tests have gained popularity as POCTs due to their inherent attractive qualities, including high sensitivity and specificity, adaptability, low cost, quick turnaround time, and ease of use. However, studies on the development of CRISPR-based POC diagnostic tests for VHFs are limited. This review summarizes the current CRISPR-based POCTs for VHFs, including Ebola virus (EBOV), Lassa virus (LASV), Dengue virus (DENV), and Crimean–Congo hemorrhagic fever virus (CCHF). The isothermal pre-amplification methods commonly paired with CRISPR-based tests, such as loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA), are also discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.
- Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
- Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB R3A 1S1, Canada.
ORCID-Profile: Kylene Wupori, Alexander Bello, James E Strong
Förderung
- Genomics Research and Development Initiative
- Canadian Safety and Security Program
- Genomics Research and Development Initiative-8
Zitieren
APA
Wupori, K., Garnett, L., Bello, A., & Strong, J. E. (2026). CRISPR-Based Detection of Viral Hemorrhagic Fevers at the Point of Care. Viruses. https://doi.org/10.3390/v18020218
Vancouver
Wupori K, Garnett L, Bello A, Strong JE. CRISPR-Based Detection of Viral Hemorrhagic Fevers at the Point of Care. Viruses. 2026. doi:10.3390/v18020218
BibTeX
@article{Wupori2026,
author = {Wupori, Kylene and Garnett, Lauren and Bello, Alexander and Strong, James E},
title = {CRISPR-Based Detection of Viral Hemorrhagic Fevers at the Point of Care},
journal = {Viruses},
year = {2026},
doi = {10.3390/v18020218}
}
EUVIMED